<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01569698</url>
  </required_header>
  <id_info>
    <org_study_id>2010-A00670-39</org_study_id>
    <nct_id>NCT01569698</nct_id>
  </id_info>
  <brief_title>Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury</brief_title>
  <acronym>EPURE</acronym>
  <official_title>Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Limited prospective data is available to compare morbidity and mortality between renal
      replacement modalities in pediatric acute renal failure.

      In the absence of clear standard of care, the choice of the extra renal replacement therapy
      modality is subject to clinical judgement, practical aspects, and costs.

      This study will supply important data about usual modalities of pediatric acute extra renal
      replacement therapy and their impact on patient outcome and renal recovery. An obvious next
      step will be to conduct a randomized controlled trial comparing the different strategies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In children, there are limited data on extra renal replacement therapy. Pediatric studies are
      often retrospective, or often limited to specific disease processes or specific extra renal
      therapy. The lack of large studies including different usual modalities in pediatrics limits
      any formal recommendation on use in relation to patient outcomes, including renal recovery
      and mortality. Some of the issues that need consideration are the choice of dialysis modality
      (including Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal
      Dialysis), the indications for and timing of dialysis intervention, the dose of dialysis and
      their effects on outcomes from acute kidney injury in children.

      This study will supply important data about pediatric acute extra renal replacement therapy,
      including the epidemiology of pediatric acute kidney injury leading to extra renal
      replacement therapy, the variety of the treatment modalities, and their effects on the course
      of the disease.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>extra renal replacement therapy</measure>
    <time_frame>at day 60 +/- 7</time_frame>
    <description>To describe usual modalities of pediatric acute extra renal replacement therapy including Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Current incidence</measure>
    <time_frame>at day 60 +/- 7</time_frame>
    <description>Current incidence of the use of extra renal replacement therapy in pediatric acute renal failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>etiologies</measure>
    <time_frame>at day 0</time_frame>
    <description>Acute kidney injury etiologies leading to extra renal replacement therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk factors of mortality and non recovery of the renal function</measure>
    <time_frame>at day 60</time_frame>
    <description>Risk factors of mortality and non recovery of the renal function at day 60 in child acute kidney injur treated by extra renal replacement therapy (including, among others, the choice of dialysis modality (i.e. Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis), the indications for and timing of dialysis intervention, and the dose of dialysis).
Urea, blood pressure, creatinine, report proteinuria / creatinuria, renal disease, acute graft</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Kidney Failure, Acute</condition>
  <arm_group>
    <arm_group_label>extrarenal replacement therapy</arm_group_label>
    <description>Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>acute extra renal replacement therapy</intervention_name>
    <description>usual modalities of pediatric acute extra renal replacement therapy : Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis</description>
    <arm_group_label>extrarenal replacement therapy</arm_group_label>
    <other_name>Non applicable.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children with an acute renal failure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &lt; 18 years, including the newborn ;

          -  Acute kidney injury as defined by pRIFLE classification requiring extra renal
             replacement therapy, whatever is the method.

        Exclusion Criteria:

          -  Treatment by extra renal replacement therapy for terminal renal failure;

          -  History of renal transplantation;

          -  Extra renal replacement therapy for an inborn errors of metabolism without acute renal
             failure;

          -  Extra renal replacement therapy in the context of a drug intoxication without acute
             renal failure;

          -  Treatment by technique in MARS (Molecular Adsorbent Recirculating System);

          -  Modified ultrafiltration during surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theophile Gaillot, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Théophile Gaillot, MD</last_name>
    <phone>+33-299-263-186</phone>
    <email>theophile.gaillot@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pediatric intensive care - Centre mère enfants</name>
      <address>
        <city>Sainte-Foy</city>
        <zip>G1V 4G2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dennis Bailey, MD</last_name>
      <email>dennis.bailey@mail.chuq.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Dennis Bailey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe Jouvet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique Phan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatric intensive care -</name>
      <address>
        <city>Sherbrooke</city>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Santschi, MD</last_name>
      <email>miriamsantschi@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Miriam Santschi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie Bertelle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Angers University Hospital</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerard Champion, MD</last_name>
      <email>Gechampion@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Gerard Champion, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Besançon University Hospital</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Nobili, MD</last_name>
      <email>fnobili@chu-besancon.fr</email>
    </contact>
    <investigator>
      <last_name>François Nobili, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatry - Bordeaux University Hospital</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérôme Harambat, MD</last_name>
      <email>jerome.harambat@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Jérôme Harambat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reanimation pediatric - Morvan Hospital</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Armelle Garenne, MD</last_name>
      <email>armelle.garenne@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Armelle Garenne, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatry - Cote De Nacre University Hospital</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Eckart, MD</last_name>
      <email>eckart-p@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Eckart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatric nephrology - Hôpital Couple-enfants</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guylhène Bourdat-Michel, MD</last_name>
      <email>gbourdatmichel@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Guylhène Bourdat-Michel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bicêtre University Hospital</name>
      <address>
        <city>Le Kremlin Bicêtre</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Chevret, MD</last_name>
      <email>laurent.chevret@bct.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent Chevret, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatry - Hopital de la Mère et de l'Enfant</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Guigonis, MD</last_name>
      <email>v.guigonis@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Vincent Guigonis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Anesthesy-Pediatric reanimation - Nord University Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13920</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice Michel, MD</last_name>
      <email>fabrice.michel@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Fabrice Michel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatric Nephrology and dianetology - Arnaud de Villeneuve Hospital</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis Morin, MD</last_name>
      <email>d-morin@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Denis Morin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatric reanimation - Hôpital mère-enfant</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel Liet, MD</last_name>
      <email>jeanmichel.liet@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Michel Liet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gwenaelle Roussey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Réanimation et Surveillance - Robert Debre Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75007</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane Dauger, MD</last_name>
      <email>stephane.dauger@rdb.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Stéphane Dauger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatry - Reims University Hospital</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Piétrement, MD</last_name>
      <email>cpietrement@chu-reims.fr</email>
    </contact>
    <investigator>
      <last_name>Christine Piétrement, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sahar Bayat Makoei, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilbert Landthaler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Pierre Lavocat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nephrology - Hôpital des enfants</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud Garnier, MD</last_name>
      <email>garnier.a@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Arnaud Garnier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hubert Nivet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>JULIE CHANTREUIL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>NICOLAS ROULLET RENOLEAU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>THIERRY PEREZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nephrology - Pediatric emergency - Clocheville University Hospital</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvie Cloarec, MD</last_name>
      <email>S.CLOAREC@chu-tours.fr]</email>
    </contact>
    <investigator>
      <last_name>Sylvie Cloarec, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tim Ulinski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michelle Hall, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laure Collard, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johan Vandewalle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paloma Parvex, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Rimensberger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatric reanimation - Brabois Hospital</name>
      <address>
        <city>Vandoeuvre Les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florent Girard, MD</last_name>
      <email>f.girard@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Florent Girard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe hospitalier Sud Reunion</name>
      <address>
        <city>Reunion</city>
        <country>Réunion</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Dusang, MD</last_name>
      <email>benjamin.dusang@chr-reunion.fr</email>
    </contact>
    <investigator>
      <last_name>Benjamin Dusang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hugues Flodrops, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Audrey Breining, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel Tsimaratos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
    <country>Réunion</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2012</study_first_submitted>
  <study_first_submitted_qc>March 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2012</study_first_posted>
  <last_update_submitted>September 6, 2016</last_update_submitted>
  <last_update_submitted_qc>September 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pediatric</keyword>
  <keyword>acute renal failure</keyword>
  <keyword>acute extra renal replacement therapy</keyword>
  <keyword>Intermittent Hemodialysis</keyword>
  <keyword>Continuous Renal Replacement Therapies</keyword>
  <keyword>Peritoneal Dialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

